++++ Change of ¼ ++++ Please read marked text carefully!

++++
VZV IgM Stability
The reagents are stable up to the stated expiry dates on the individual
ELISA Test for the Detection of IgM Antibodies labels when stored at 2...8°C.
to Varicella Zoster Virus in Human Serum After opening reagents have to be stored at 2...8°C and used within 60
days.
Package Size
[REF] 51110 96 Tests Complete Test Kit [MIC] (Code: VZV M)
[IVD] − sealed in an aluminium bag with a desiccant.
− must be at room temperature before opening,
Intended Use
− unused: return with the desiccant to the zip-lock bag and store in this
The VZV IgM ELISA is intended for the detection of Immunoglobulin M way at 2...8°C.
(IgM) class antibodies to Varicella zoster virus (VZV) in human serum.
− Do not touch the upper rim or the bottom of the wells with fingers.
Humans are the only known reservoir for VZV. About 3 million cases of
primary chickenpox occur annually. Chickenpox in children is generally a Reagent Preparation
benign, self-limited infection. Typically, the child presents with fever, Bring all reagents to room temperature (15...25°C) before use.
malaise, and a generalised skin eruption. Infection in the adult is more
severe than in childhood, with varicella pneumonitis being a significant Reagents not in use should always be stored at 2...8°C.
concern.
Notes
Shingels (zoster) is also a common disorder caused by VZV, with nearly The general purpose reagents [DIL-M] 5111, [WS] 5102, [SUB] 5103,
10% of the general population afflicted at some time. [STOP] 5104 are interchangeable between different lots and kits. For IgM
Serology is a routine diagnostic procedure and also used to monitor the tests use only IgM dilution buffer [DIL-M] 5111.
progress of the infection. All other reagents are specific for the individual package lot and must not
be interchanged with other lots. No reagents of other manufacturers
Principle - Classic EIA -
should be used along with reagents of this kit.
The HUMAN VZV IgM ELISA is based on the classical ELISA technique. The
microtiter strip wells as a solid phase are coated with cell culture derived Working Wash Solution [WASH]
VZV antigens (VZV Ag). In the first incubation step corresponding specific − dilute [WS]20x] 5102 1+19 with fresh deionised water, e.g. 50 ml
antibodies (VZV-IgM-Ab) present in patient specimens or controls bind to [WS]20x] 5102 + 950 ml = 1000 ml.
the antigens at the solid phase. The sample dilution buffer contains anti-
human IgG to prevent rheumatoid factor (RF) interference and − Stability: up to 60 days at 15...25°C.
competition from specific IgG present in the specimen.
Specimen
At the end of the incubation unbound components are washed out. For Serum
the second incubation step anti-IgM conjugate (anti-human IgM
Do not use highly lipemic or hemolysed specimens.
antibodies, peroxidase conjugated) is added which binds specifically to
IgM class antibodies resulting in the formation of typical Specimens may be stored for 7 days at 2...8°C or longer at -20°C. Freeze
immunocomplexes. After a second washing step to remove excess and thaw once only. Thawed specimen must be homogenised. Eliminate
conjugate, TMB/Substrate is added (Step 3). A blue colour develops particulate matter by centrifugation or filtration.
changing to yellow after stopping the reaction. The intensity of the colour
is directly proportional to the VZV-IgM-Ab concentration in the specimen. Procedure
Follow the procedure exactly as described.
Reagents and Contents
[MIC] 12 Microtiter Strips (in 1 strip holder) Procedural Notes
(Code VZV M) P1: Do not mix caps of vials (risk of contamination). Do not use reagents
8-well snap-off strips after their expiration date.
coated with VZV antigen (cell culture derived) P2: Do not use reagents that could be contaminated or look or smell
[NC] 2.5 ml VZV IgM Negative Control (green cap) different than usual.
ready for use, human P3: Record specimens and controls carefully on the spread sheet
[PC] 2.5 ml VZV IgM Positive Control (red cap) supplied with the kit.
ready for use, human P4: [MIC] - select the required number of Microtiter Strips.
[DIL-M] 100 ml Dilution Buffer IgM (blue cap) P5: Run duplicates for controls. Pipette controls and specimen on the
5111 ready for use, coloured green pH 6.5 ± 0.2 bottom in the microwells.
Phosphate buffer 10 mmol/l
P6: Always add reagents in the same order and timing to minimise
NaCl 8 g/l
reaction time differences between wells. This is important for
Albumin 10 g/l
reproducible results. Pipetting of specimens should not exceed 5
Anti-human-IgG (goat)
minutes. Otherwise pipette the controls in the indicated positions at
[CON] 12 ml Anti-IgM Conjugate (white cap) half way time of the series. If more than 1 plate is used, repeat the
ready for use, coloured red controls for each plate.
Anti-human IgM (rabbit), peroxidase-conjugated
P7: Avoid/remove air bubbles prior to incubations and reading of
[WS]20x] 50 ml Washing Solution (white cap) absorbance.
5102 Concentrate for about 1000 ml pH 7.2 ± 0.2
P8: [SUB] – incubate in the dark. [SUB] initiates a kinetic reaction, which
Tris buffer 10 mmol/l
is terminated by [STOP].
NaCl 8 g/l
P9: [DIL-M] – turbidity after addition of the sample has no influence on
[SUB] 13 ml Substrate Reagent (black cap)
the results.
5103 ready for use, colourless to bluish pH 3.7 ± 0.2
3,3', 5,5'-tetramethylbenzidin (TMB) 1.2 mmol/l P10: Always firmly close vials with the proper caps after use.
Hydrogen peroxide 3 mmol/l
Wash Procedure
[STOP] 15 ml Stop Solution (red cap)
The wash procedure is critical. Insufficient washing will result in poor
5104 Sulphuric acid, ready for use 0.5 mol/l
precision or falsely high absorbance.
2 Adhesive Strips
W1: Remove Adhesive Strips, aspirate off the contents into 5% sodium
Preservatives: Total concentration < 0.1% hypochlorite solution and add [WASH] to each well, aspirate off after
30 sec. soak time and repeat washing 3 resp. 4 times.
Additional materials recommended but not supplied with the kit
W2: In case of automatic washers fill and prime with [WASH].
Micropipettes, ELISA washer, microplate reader equipped with 450 nm or
Subsequently wash strips 4 resp. 5 times. Ensure the washer fills all
with 450/630–690 nm filters, deionised water.
wells completely and aspirates off efficiently after 30 sec. (remaining
liquid: < 15 µl).
W3: After washing, remove remaining liquid by tapping the plate
upside down on tissue paper.
Pipetting Scheme
Performance Characteristics
Reagents and specimens should be at room temperature before use. Typical performance data can be found in the Verification Report,
Sample Preparation: accessible via
Dilute the patient’s sera 1+100 with [DIL-M] 5111, e.g. 10 µl serum + www.human.de/data/gb/vr/el-vzvm.pdf or
1 ml [DIL-M] 5111, mix thoroughly (see P9). www.human-de.com/data/gb/vr/el-vzvm.pdf
Incubate diluted samples at least 5 min. prior to further processing.
If the performance data are not accessible via internet, they can be
Diluted samples can be stored up to 24 h at 2...8°C before testing. obtained free of charge from your local distributor.
Controls are ready for use.
Note
Step 1 Well [µl]
The components of the kit are stable until the expiry date even after
A1 B1/C1 D1/E1 F1... opening. However, a potential contamination is directly related to the
Blank [NC] [PC] Sample
number of samplings. The 60 days limit after first use is set for safety
[NC] in duplicate -- 100 -- -- reasons.
[PC] in duplicate -- -- 100 --
Safety Notes
Diluted samples -- -- -- 100
[STOP] Warning
[MIC] cover with Adhesive Strips
· Hazard statements
Incubate 30 min. at 17...25°C
H315 Causes skin irritation.
Wash 4 times as described (see W1 - W3)
H319 Causes serious eye irritation.
[WASH] 350 350 350 350
[SUB] Danger
Step 2
[CON] -- 100 100 100 · Hazard statements
[MIC] cover with Adhesive Strips H360D May damage the unborn child.
Incubate 30 min. at 17...25°C · Precautionary statements
Wash 5 times as described (see W1 - W3) [NC] [PC] [DIL-M] [CON] [WS]20x] [SUB] [STOP]
[WASH] 350 350 350 350 P234 Keep only in original container.
Step 3 P260 Do not breathe dust/fume/gas/mist/vapours/spray.
[SUB] 5103 100 100 100 100 P262 Do not get in eyes, on skin, or on clothing.
Incubate 15 min. at 17...25°C (see P8) P281 Use personal protective equipment as required.
[STOP] 5104 100 100 100 100 P303+P361+P353 IF ON SKIN (or hair): Take off immediately all
Mix carefully contaminated clothing. Rinse skin with water/shower.
Zero the ELISA microtiter plate reader (HUMAREADER) using the P305+P351+P338 IF IN EYES: Rinse cautiously with water for several
substrate blank in well A1. minutes. Remove contact lenses, if present and easy to do. Continue
Measure the absorbance at 450 nm as soon as possible or within rinsing.
30 min. after terminating of the reaction, using a reference wavelength P337+P313 If eye irritation persists: Get medical advice/attention.
of 630-690 nm (if available). P401 Store in accordance with local/regional/national/international
The absorbance of controls and specimen is determined by using ELISA regulations.
microplate readers or automated ELISA systems (like HUMAN´s P501 Dispose of contents/container in accordance with
HumaReader or ELISYS line). Results for patient samples are obtained by local/regional/national/international regulations.
comparison with a cut-off value.
The controls have been checked on donor level for HCV and HIV-1/2
Calculation of Control Values and Cut-off antibodies and HBsAg and found negative.
Mean absorbance values of [NC] in wells B1 and C1 (MNC) and [PC] in
Literature
wells D1 and E1 (MPC) are calculated according to:
1. Engvall, E., Perlmann, P., Immunochemistry 8, 871-874 (1971)
A450 (B1) + A450 (C1) A450 (D1) + A450 (E1) 2. Engvall, E., Perlmann, P., J. Immunol. 109, 129-135 (1972)
MNC = ───────────────── ; MPC = ─────────────────
3. Remington, J.S., Klein, J.O., Infectious diseases of the fetus and
2 2
newborn infant. Sanders, Philadelphia, London, Toronto (1976)
Cut-off value COV = MNC + (0.2 x MPC)
4. Bidwell, D.E. et al., J. Infect. Dis. 136, Supplement 274-278 (1977)
The test run may be considered valid provided that the following criteria
5. Volk, W.A., Essentials of Medical Microbiology. Second ed., J.B.
are met:
Lippincott Company, Philadelphia, New York, San Jose, Toronto, 576-
1. Substrate blank in well A1 < 0.150 578 (1982)
2. MNC ≤ 0.250 6. Schmidt, N.J., J. Med. Virol. 9, 27-36 (1982).
3. MPC ≥ 0.400
4. MPC : MNC ≥ 3 EL-VZVM INF 5111001 GB 03-2018-22M |
Interpretation of Results
A450 (patient) ≥ COV + 15%: anti-VZV-IgM-Ab-positive
A450 (patient) < COV -15%: anti-VZV-IgM-Ab-negative
Due to physiological and analytical variations patient results lying 15%
above or below the calculated cut-off are equivocal. It is recommended to
measure these samples in parallel with a fresh sample taken 7 to 14 days
later. The trend between the specific antibody levels should be used for
interpretation, also taking into consideration the specific IgG
concentration (HUMAN ELISA IgG), the patient history and additional
investigations. Repeatedly reactive or equivocal samples may be
subjected to a confirmatory test.
Because of serological cross-reactivity between VZV and Herpes Simplex
virus, and because of possible reactivation of latent VZV infection caused
by infection with Epstein Barr virus, positive VZV IgM results may occur in
sera from patients with infection due to these other members of the
Herpes viridae family. The possibility of infections with these pathogens
should therefore be investigated before interpretation of results.

Human Gesellschaft für Biochemica und Diagnostica mbH

Max-Planck-Ring 21 · 65205 Wiesbaden · Germany
Telefon +49 6122-9988-0 · Telefax +49 6122-9988-100 · e-Mail human@human.de